Related Experiment Video

Updated: May 30, 2026

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory
10:03

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory

Published on: February 28, 2013

Macrovascular effects and safety issues of therapies for type 2 diabetes

Jorge Plutzky1

  • 1Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA. jplutzky@rics.bwh.harvard.edu

The American Journal of Cardiology
|August 2, 2011
PubMed

Insights

Type 2 diabetes significantly increases cardiovascular disease (CVD) risk, impacting both microvascular and macrovascular health. Effective glycemic control and managing risk factors are crucial for patient outcomes.

Area of Science:

  • Endocrinology and Metabolism
  • Cardiology
  • Diabetology

Background:

  • Type 2 diabetes is a major independent risk factor for cardiovascular disease (CVD), encompassing coronary artery disease (CAD), stroke, and heart failure.
  • Cardiovascular complications represent the leading cause of mortality and comorbidity in individuals with diabetes.
  • Diabetes-related vascular complications include microvascular issues (nephropathy, neuropathy, retinopathy) and macrovascular diseases.

Purpose of the Study:

  • To examine the established impact of glycemic control on microvascular complications in type 2 diabetes.
  • To investigate the evidence linking glycemic control to the reduction of macrovascular diseases, such as CAD and stroke.
  • To address concerns regarding the cardiovascular safety of antidiabetic therapies and optimize patient care strategies.

Main Methods:

  • Review of existing literature on glycemic control and cardiovascular outcomes in type 2 diabetes.
  • Analysis of studies investigating the relationship between antidiabetic medications and cardiovascular safety.
  • Synthesis of evidence on the interplay between glycemic control, traditional cardiovascular risk factors, and diabetes management.

Main Results:

  • Glycemic control is well-established in mitigating microvascular complications.
  • Evidence suggests glycemic control can also limit macrovascular complications, though this is more debated.
  • Cardiovascular safety of antidiabetic therapies remains a significant concern, necessitating careful treatment selection.

Conclusions:

  • Optimal glycemic control is essential for managing both microvascular and macrovascular complications in type 2 diabetes.
  • Integrated management of cardiovascular risk factors alongside glycemic control is critical.
  • Further research and careful consideration of antidiabetic drug safety profiles are needed to guide optimal patient care strategies.

More Related Videos

Combined Intravital Microscopy and Contrast-enhanced Ultrasonography of the Mouse Hindlimb to Study Insulin-induced Vasodilation and Muscle Perfusion08:22

Combined Intravital Microscopy and Contrast-enhanced Ultrasonography of the Mouse Hindlimb to Study Insulin-induced Vasodilation and Muscle Perfusion

Published on: March 20, 2017

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes07:22

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes

Published on: March 7, 2025

Related Concept Videos

Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Complications of Diabetes Mellitus01:22

Complications of Diabetes Mellitus

Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...